Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Itron (ITRI) Financials

Itron logo
$80.46 -0.34 (-0.42%)
As of 10:12 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Itron

Annual Income Statements for Itron

This table shows Itron's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
13 32 57 -99 49 -58 -81 -9.73 97 239 301
Consolidated Net Income / (Loss)
15 35 60 -97 52 -57 -78 -9.55 98 241 303
Net Income / (Loss) Continuing Operations
15 35 60 -97 52 -57 -78 -9.55 98 241 303
Total Pre-Tax Income
37 85 135 -109 73 -57 -124 -16 127 285 342
Total Operating Income
53 101 155 -50 133 -10 -79 -7.44 129 264 313
Total Gross Profit
557 663 677 730 752 602 573 522 714 839 892
Total Revenue
1,884 2,013 2,018 2,376 2,502 2,173 1,982 1,796 2,174 2,441 2,367
Operating Revenue
1,884 2,013 2,018 2,376 2,502 2,173 1,982 1,796 2,174 2,441 2,367
Total Cost of Revenue
1,327 1,351 1,341 1,646 1,750 1,571 1,408 1,273 1,460 1,602 1,475
Operating Cost of Revenue
1,327 1,351 1,341 1,646 1,750 1,571 1,408 1,273 1,460 1,602 1,475
Total Operating Expenses
504 562 522 780 620 613 652 530 585 575 579
Selling, General & Admin Expense
156 320 325 423 347 277 301 290 313 339 353
Research & Development Expense
162 168 169 208 202 194 197 185 209 215 207
Amortization Expense
32 25 21 72 64 45 36 26 19 18 18
Restructuring Charge
-7.26 49 6.42 77 6.28 37 55 -14 44 2.68 0.93
Other Special Charges / (Income)
- - - 0.00 0.00 60 64 3.51 0.67 0.60 0.08
Total Other Income / (Expense), net
-16 -16 -20 -59 -60 -46 -45 -8.30 -1.48 20 29
Interest Expense
12 14 14 58 52 44 29 6.72 8.35 15 22
Interest & Investment Income
0.76 0.87 2.13 2.15 1.85 3.00 1.56 2.63 9.31 35 48
Other Income / (Expense), net
-4.22 -3.71 -8.58 -3.41 -9.05 -5.24 -17 -4.21 -2.45 1.22 3.27
Income Tax Expense
22 50 74 -13 21 0.24 -46 -6.20 29 43 39
Net Income / (Loss) Attributable to Noncontrolling Interest
2.33 3.28 2.95 2.67 3.41 1.08 2.96 0.19 1.40 2.02 2.28
Basic Earnings per Share
$0.33 $0.83 $1.48 ($2.53) $1.24 ($1.44) ($1.83) ($0.22) $2.13 $5.27 $6.62
Weighted Average Basic Shares Outstanding
38.22M 38.21M 38.66M 39.24M 39.56M 40.25M 44.30M 45.10M 45.42M 45.37M 45.49M
Diluted Earnings per Share
$0.33 $0.82 $1.45 ($2.53) $1.23 ($1.44) ($1.83) ($0.22) $2.11 $5.18 $6.50
Weighted Average Diluted Shares Outstanding
38.51M 38.64M 39.39M 39.24M 39.98M 40.25M 44.30M 45.10M 45.84M 46.19M 46.32M
Weighted Average Basic & Diluted Shares Outstanding
-27M 38.30M 38.70M 39.20M 39.96M 40.46M 45.01M 45.29M 45.58M 45.18M 44.94M

Quarterly Income Statements for Itron

This table shows Itron's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
40 44 52 51 78 58 65 68 66 102 53
Consolidated Net Income / (Loss)
40 45 52 52 79 59 65 69 66 103 54
Net Income / (Loss) Continuing Operations
40 45 52 52 79 59 65 69 66 103 54
Total Pre-Tax Income
56 49 65 67 82 70 82 83 91 86 67
Total Operating Income
55 49 63 65 74 63 76 76 82 79 68
Total Gross Profit
187 196 205 210 210 214 217 224 220 232 236
Total Revenue
561 577 603 609 615 613 607 607 582 572 587
Operating Revenue
561 577 603 609 615 613 607 607 582 572 587
Total Cost of Revenue
374 381 398 399 406 399 390 383 362 340 351
Operating Cost of Revenue
374 381 398 399 406 399 390 383 362 340 351
Total Operating Expenses
132 147 143 146 136 151 141 147 138 153 169
Selling, General & Admin Expense
77 82 86 88 80 85 87 88 83 95 105
Research & Development Expense
52 54 52 53 51 58 50 54 50 53 55
Amortization Expense
4.66 4.49 3.99 4.51 4.81 4.52 4.48 4.54 4.40 4.61 8.17
Restructuring Charge
-0.62 7.12 0.20 -0.10 -0.72 3.30 -0.55 1.24 0.19 0.06 0.21
Other Special Charges / (Income)
0.05 -0.01 0.02 -0.07 0.70 -0.06 0.08 0.00 0.00 - 0.00
Total Other Income / (Expense), net
0.84 0.19 2.42 2.39 8.49 7.12 6.07 7.07 8.92 7.15 -0.38
Interest Expense
2.45 1.87 1.89 2.29 5.61 5.59 5.59 5.65 5.65 5.56 5.81
Interest & Investment Income
2.64 3.35 3.85 5.13 13 12 12 12 14 11 5.66
Other Income / (Expense), net
0.65 -1.28 0.46 -0.45 0.68 0.53 -0.05 0.41 1.00 1.92 -0.23
Income Tax Expense
15 4.56 13 15 3.52 11 17 15 24 -17 14
Net Income / (Loss) Attributable to Noncontrolling Interest
0.17 0.52 0.07 0.54 0.95 0.46 -0.12 0.41 0.61 1.38 0.13
Basic Earnings per Share
$0.88 $0.98 $1.13 $1.12 $1.73 $1.29 $1.44 $1.50 $1.43 $2.25 $1.20
Weighted Average Basic Shares Outstanding
45.46M 45.42M 45.65M 45.75M 44.98M 45.37M 45.34M 45.63M 45.75M 45.49M 44.73M
Diluted Earnings per Share
$0.87 $0.97 $1.12 $1.10 $1.70 $1.26 $1.42 $1.47 $1.41 $2.20 $1.18
Weighted Average Diluted Shares Outstanding
45.95M 45.84M 46.36M 46.53M 45.84M 46.19M 46.17M 46.38M 46.66M 46.32M 45.47M
Weighted Average Basic & Diluted Shares Outstanding
45.49M 45.58M 45.87M 44.96M 45.09M 45.18M 45.59M 45.72M 45.80M 44.94M 44.34M

Annual Cash Flow Statements for Itron

This table details how cash moves in and out of Itron's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
19 2.55 345 -357 28 57 -33 39 100 749 -31
Net Cash From Operating Activities
73 116 191 110 173 110 155 25 125 238 406
Net Cash From Continuing Operating Activities
73 116 191 110 173 110 155 25 125 238 406
Net Income / (Loss) Continuing Operations
15 35 60 -97 52 -57 -78 -9.55 98 241 303
Consolidated Net Income / (Loss)
15 35 60 -97 52 -57 -78 -9.55 98 241 303
Depreciation Expense
76 68 63 122 114 97 84 67 56 56 50
Amortization Expense
2.13 1.08 1.07 7.05 5.63 4.13 18 3.50 3.66 5.49 7.08
Non-Cash Adjustments To Reconcile Net Income
37 30 12 54 33 106 119 86 42 64 68
Changes in Operating Assets and Liabilities, net
-57 -18 55 22 -33 -41 12 -122 -75 -129 -22
Net Cash From Investing Activities
-49 -48 -148 -863 -48 -41 -35 41 -23 -63 -350
Net Cash From Continuing Investing Activities
-49 -48 -148 -863 -48 -41 -35 41 -23 -63 -350
Purchase of Property, Plant & Equipment
-44 -44 -49 -60 -61 -46 -35 -20 -27 -31 -23
Acquisitions
-5.75 -0.95 -99 -803 0.00 0.00 -8.67 0.02 0.00 -34 -325
Divestitures
- - - - 0.00 1.13 3.14 56 -0.77 0.41 0.28
Other Investing Activities, net
0.72 -3.03 0.70 0.37 13 4.04 5.33 4.31 4.35 0.85 -2.00
Net Cash From Financing Activities
7.74 -63 302 396 -98 -12 -153 -19 -3.51 580 -97
Net Cash From Continuing Financing Activities
7.74 -63 302 396 -98 -12 -153 -19 -3.51 580 -97
Repayment of Debt
-70 -82 -37 -392 -147 -420 -961 -5.22 -7.18 -25 -4.78
Repurchase of Common Equity
-38 - 0.00 0.00 -25 0.00 -8.03 -17 0.00 -100 -100
Issuance of Debt
113 16 335 779 50 400 460 0.00 0.00 805 0.00
Issuance of Common Equity
2.66 2.89 3.61 9.17 24 8.89 440 3.45 3.67 8.32 7.32
Other Financing Activities, net
- - - - 0.00 0.00 -84 0.00 0.00 -109 0.00
Effect of Exchange Rate Changes
-13 -2.74 - - 0.44 0.13 - -6.85 1.89 -5.15 10
Cash Interest Paid
10 9.92 10 42 45 47 8.98 1.62 1.83 1.34 13
Cash Income Taxes Paid
29 24 29 14 12 2.69 7.07 12 55 80 56

Quarterly Cash Flow Statements for Itron

This table details how cash moves in and out of Itron's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
22 47 -1.44 620 62 69 72 101 108 -312 -308
Net Cash From Operating Activities
34 48 41 52 65 80 72 97 118 119 86
Net Cash From Continuing Operating Activities
34 48 41 52 65 80 72 97 118 119 86
Net Income / (Loss) Continuing Operations
40 45 52 52 79 59 65 69 66 103 54
Consolidated Net Income / (Loss)
40 45 52 52 79 59 65 69 66 103 54
Depreciation Expense
14 14 13 14 15 15 12 12 12 13 19
Amortization Expense
0.94 0.90 0.89 0.98 1.80 1.82 1.78 1.80 1.82 1.68 1.85
Non-Cash Adjustments To Reconcile Net Income
9.07 10 16 13 13 21 19 18 17 14 26
Changes in Operating Assets and Liabilities, net
-30 -22 -40 -28 -43 -17 -27 -3.61 21 -13 -15
Net Cash From Investing Activities
-5.78 -4.31 -41 -6.67 -6.57 -9.03 -4.63 -6.02 -6.14 -333 -522
Net Cash From Continuing Investing Activities
-5.78 -4.31 -41 -6.67 -6.57 -9.03 -4.63 -6.02 -6.14 -333 -522
Purchase of Property, Plant & Equipment
-5.81 -8.58 -7.15 -7.11 -6.62 -9.68 -4.64 -6.02 -4.42 -7.81 -6.53
Acquisitions
- - -34 - - 0.02 0.00 - - -325 -515
Other Investing Activities, net
0.02 4.28 0.13 0.03 0.06 0.64 0.01 - -2.00 - 0.01
Net Cash From Financing Activities
-3.41 -0.87 1.08 576 -0.75 3.49 1.76 2.99 -2.91 -99 131
Net Cash From Continuing Financing Activities
-3.41 -0.87 1.08 576 -0.75 3.49 1.76 2.99 -2.91 -99 131
Repayment of Debt
-4.13 -2.18 -0.49 -22 -2.10 -0.52 -0.43 -0.25 -3.81 -0.29 -481
Repurchase of Common Equity
- - - - - - 0.00 - - -100 -100
Issuance of Debt
- - - - - - 0.00 - - - 805
Issuance of Common Equity
0.73 1.31 1.56 1.41 1.35 4.00 2.20 3.24 0.90 0.99 0.68
Other Financing Activities, net
- - - - - - 0.00 - - - -93
Effect of Exchange Rate Changes
-2.91 4.56 -2.68 -0.77 3.89 -5.58 2.79 7.33 -1.09 1.29 -2.90
Cash Interest Paid
0.79 0.25 0.32 0.64 3.10 -2.72 6.61 0.34 5.84 0.37 5.96
Cash Income Taxes Paid
8.38 26 14 26 19 21 35 11 2.91 7.53 3.30

Annual Balance Sheets for Itron

This table presents Itron's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,680 1,578 2,106 2,609 2,708 2,607 2,394 2,378 2,604 3,408 3,721
Total Current Assets
759 732 850 896 997 930 750 830 1,049 1,816 1,822
Cash & Equivalents
131 134 176 120 150 207 163 202 302 1,051 1,020
Accounts Receivable
331 352 398 437 473 370 298 280 304 350 368
Inventories, net
190 163 194 221 228 182 166 229 284 271 243
Other Current Assets
107 84 82 118 147 171 123 118 160 143 191
Plant, Property, & Equipment, net
190 176 201 227 233 208 163 140 129 115 112
Total Noncurrent Assets
731 669 1,056 1,486 1,477 1,469 1,481 1,408 1,426 1,476 1,786
Goodwill
468 452 556 1,117 1,104 1,132 1,099 1,039 1,053 1,052 1,345
Intangible Assets
102 72 95 258 185 133 93 65 46 43 83
Noncurrent Deferred & Refundable Income Taxes
109 94 50 65 64 76 181 212 247 310 265
Other Noncurrent Operating Assets
52 50 355 47 124 128 108 93 80 71 93
Total Liabilities & Shareholders' Equity
1,680 1,578 2,106 2,609 2,708 2,607 2,394 2,378 2,604 3,408 3,721
Total Liabilities
1,058 927 1,301 1,875 1,907 1,767 1,251 1,187 1,273 1,996 1,983
Total Current Liabilities
478 413 508 653 671 550 501 499 537 528 1,012
Short-Term Debt
11 14 20 28 0.00 18 - - - 0.00 460
Accounts Payable
186 173 262 310 328 216 193 237 200 145 156
Accrued Expenses
37 25 21 47 39 28 18 18 15 14 11
Current Deferred Revenue
73 65 41 94 100 113 83 96 124 151 188
Current Deferred & Payable Income Tax Liabilities
15 10 16 15 22 16 12 15 8.64 20 17
Current Employee Benefit Liabilities
77 82 91 89 119 86 114 89 136 137 122
Other Current Liabilities
79 44 57 70 64 73 81 43 54 61 59
Total Noncurrent Liabilities
580 514 793 1,222 1,236 1,217 750 688 736 1,468 970
Long-Term Debt
359 290 594 988 932 903 450 453 455 1,242 789
Capital Lease Obligations
- - - 0.00 69 67 - 44 33 25 20
Noncurrent Deferred & Payable Income Tax Liabilities
1.72 3.07 1.53 1.54 1.81 1.92 2.00 0.83 0.70 0.57 0.62
Noncurrent Employee Benefit Liabilities
86 84 96 92 99 119 88 58 64 60 62
Other Noncurrent Operating Liabilities
133 136 102 141 134 126 210 132 184 140 99
Total Equity & Noncontrolling Interests
623 650 806 734 801 840 1,143 1,192 1,331 1,411 1,738
Total Preferred & Common Equity
605 632 786 713 777 817 1,116 1,168 1,311 1,391 1,717
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
605 632 786 713 777 817 1,116 1,168 1,311 1,391 1,717
Common Stock
1,247 1,270 1,295 1,334 1,358 1,389 1,780 1,788 1,821 1,690 1,661
Retained Earnings
- - - - - - -516 - - -189 112
Accumulated Other Comprehensive Income / (Loss)
-642 -639 -508 -622 -581 -573 -148 -620 -510 -110 -57
Noncontrolling Interest
18 19 19 21 24 24 27 23 21 21 22

Quarterly Balance Sheets for Itron

This table presents Itron's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
2,317 2,446 2,499 2,511 2,677 3,284 3,365 3,503 3,624 3,711 3,978
Total Current Assets
809 902 970 1,010 1,097 1,689 1,755 1,903 1,989 2,144 1,525
Cash & Equivalents
215 196 233 255 301 921 983 1,123 1,224 1,332 713
Accounts Receivable
267 305 319 318 340 317 339 347 340 370 393
Inventories, net
204 265 267 276 287 292 277 282 283 255 240
Other Current Assets
123 136 151 161 169 160 157 151 141 187 179
Plant, Property, & Equipment, net
139 136 133 130 125 122 120 112 116 112 122
Total Noncurrent Assets
1,369 1,407 1,396 1,372 1,454 1,472 1,490 1,488 1,519 1,455 2,331
Goodwill
1,011 1,045 1,047 1,036 1,064 1,060 1,074 1,063 1,088 1,088 1,695
Intangible Assets
70 60 55 50 57 53 48 39 34 30 277
Noncurrent Deferred & Refundable Income Taxes
189 216 214 209 250 284 290 315 319 260 258
Other Noncurrent Operating Assets
99 87 80 77 83 76 78 72 78 77 102
Total Liabilities & Shareholders' Equity
2,317 2,446 2,499 2,511 2,677 3,284 3,365 3,503 3,624 3,711 3,978
Total Liabilities
1,200 1,252 1,270 1,254 1,291 2,023 1,997 1,994 1,989 1,997 2,349
Total Current Liabilities
502 537 560 556 578 535 521 983 973 987 574
Short-Term Debt
- - - - - - - 458 458 459 0.00
Accounts Payable
236 245 235 224 224 185 153 164 123 145 173
Accrued Expenses
18 18 18 16 16 15 14 15 13 13 13
Current Deferred Revenue
111 131 140 137 157 160 161 188 196 184 223
Current Deferred & Payable Income Tax Liabilities
14 21 14 17 28 13 14 18 14 16 22
Current Employee Benefit Liabilities
78 77 100 107 94 106 119 90 107 110 92
Other Current Liabilities
47 44 53 55 60 57 61 50 62 60 51
Total Noncurrent Liabilities
697 715 710 698 713 1,488 1,475 1,011 1,016 1,010 1,776
Long-Term Debt
452 453 454 454 455 1,240 1,241 786 787 788 1,574
Capital Lease Obligations
47 - - 33 - - - - - 23 28
Noncurrent Deferred & Payable Income Tax Liabilities
1.72 0.85 0.85 0.82 0.68 0.67 0.62 0.62 0.66 0.81 9.62
Noncurrent Employee Benefit Liabilities
71 59 60 58 63 62 65 61 66 66 60
Other Noncurrent Operating Liabilities
126 202 196 152 194 186 169 163 163 133 104
Total Equity & Noncontrolling Interests
1,117 1,194 1,229 1,258 1,385 1,261 1,369 1,509 1,634 1,713 1,629
Total Preferred & Common Equity
1,094 1,171 1,205 1,238 1,365 1,240 1,348 1,488 1,613 1,693 1,607
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,094 1,171 1,205 1,238 1,365 1,240 1,348 1,488 1,613 1,693 1,607
Common Stock
1,783 1,796 1,804 1,811 1,834 1,663 1,674 1,709 1,729 1,746 1,511
Retained Earnings
- -537 -513 - -377 -325 -247 -124 -55 10 165
Accumulated Other Comprehensive Income / (Loss)
-689 -88 -86 -574 -92 -98 -78 -96 -60 -63 -69
Noncontrolling Interest
23 23 24 20 21 21 20 21 21 20 22

Annual Metrics And Ratios for Itron

This table displays calculated financial ratios and metrics derived from Itron's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.29% 6.88% 0.25% 17.73% 5.32% -13.15% -8.82% -9.39% 21.06% 12.29% -3.02%
EBITDA Growth
36.89% 31.50% 26.34% -63.70% 218.76% -64.79% -93.38% 932.41% 217.09% 76.00% 14.01%
EBIT Growth
779.47% 100.05% 50.38% -136.30% 332.83% -112.65% -518.63% 87.95% 1,184.97% 109.88% 19.22%
NOPAT Growth
6,259.95% 95.76% 65.75% -150.17% 373.76% -107.64% -662.86% 90.62% 2,010.03% 125.03% 23.97%
Net Income Growth
167.28% 133.64% 71.88% -260.30% 154.27% -208.51% -37.66% 87.81% 1,129.83% 145.25% 25.80%
EPS Growth
155.00% 148.48% 76.83% -274.48% 148.62% -217.07% -27.08% 87.98% 1,059.09% 145.50% 25.48%
Operating Cash Flow Growth
-44.84% 57.93% 65.19% -42.64% 57.48% -36.64% 41.35% -84.17% 410.09% 90.58% 70.44%
Free Cash Flow Firm Growth
-67.92% 18.25% -527.30% -20.07% 117.36% -67.37% 464.75% -145.31% 212.73% 99.98% -171.26%
Invested Capital Growth
-5.31% -4.70% 51.30% 31.21% 1.34% -1.89% -11.76% 3.92% 2.05% 5.65% 21.98%
Revenue Q/Q Growth
0.50% -0.04% 2.80% 1.55% 1.68% -4.53% -1.96% -1.00% 5.31% 1.48% -1.71%
EBITDA Q/Q Growth
103.85% 10.82% 7.74% -7.33% -0.84% -0.09% -96.21% 202.50% 22.63% 5.73% 4.24%
EBIT Q/Q Growth
329.67% 22.29% 11.14% -59.74% -1.14% 22.33% -328.88% 91.12% 40.87% 6.11% 5.79%
NOPAT Q/Q Growth
291.09% 10.91% -18.37% -65.57% -16.88% 26.45% -496.72% 94.16% 27.28% 3.69% 17.69%
Net Income Q/Q Growth
134.04% 9.96% -14.59% 19.07% -17.16% 11.29% -4,900.61% 89.38% 30.46% 6.01% 17.17%
EPS Q/Q Growth
128.21% 9.33% -15.20% 19.17% -18.00% 10.56% -2,714.29% 89.37% 29.45% 5.93% 16.91%
Operating Cash Flow Q/Q Growth
100.47% -14.24% 28.89% -23.91% 1.39% -5.03% -14.05% -52.13% 95.13% 15.50% 10.77%
Free Cash Flow Firm Q/Q Growth
-32.29% 7.00% -853.36% 37.75% -18.90% -26.22% -19.55% -109.79% 714.55% 74.89% -137.95%
Invested Capital Q/Q Growth
-3.44% -3.75% 27.43% -0.16% -0.29% 0.39% -2.08% 6.11% 1.79% -1.51% 20.26%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
29.56% 32.91% 33.53% 30.74% 30.06% 27.71% 28.93% 29.08% 32.84% 34.39% 37.69%
EBITDA Margin
6.73% 8.28% 10.43% 3.22% 9.74% 3.95% 0.29% 3.26% 8.55% 13.40% 15.75%
Operating Margin
2.81% 5.02% 7.67% -2.09% 5.30% -0.48% -4.00% -0.41% 5.93% 10.82% 13.23%
EBIT Margin
2.58% 4.83% 7.25% -2.23% 4.94% -0.72% -4.88% -0.65% 5.82% 10.87% 13.36%
Profit (Net Income) Margin
0.80% 1.74% 2.99% -4.06% 2.09% -2.62% -3.95% -0.53% 4.52% 9.88% 12.81%
Tax Burden Percent
40.44% 41.42% 44.77% 88.48% 71.77% 100.42% 63.24% 60.64% 77.18% 84.74% 88.63%
Interest Burden Percent
76.29% 86.99% 91.99% 205.55% 59.07% 362.23% 128.00% 135.11% 100.76% 107.24% 108.20%
Effective Tax Rate
59.56% 58.58% 55.23% 0.00% 28.23% 0.00% 0.00% 0.00% 22.82% 15.26% 11.37%
Return on Invested Capital (ROIC)
2.41% 4.97% 6.72% -2.42% 5.80% -0.44% -3.64% -0.36% 6.62% 14.35% 15.36%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.41% 1.66% 3.73% -11.69% 0.90% -6.52% -7.90% -1.85% 6.15% 23.54% 26.51%
Return on Net Nonoperating Assets (RNNOA)
-0.14% 0.54% 1.56% -10.12% 1.03% -6.49% -4.26% -0.46% 1.17% 3.23% 3.91%
Return on Equity (ROE)
2.27% 5.51% 8.28% -12.55% 6.83% -6.93% -7.90% -0.82% 7.79% 17.58% 19.26%
Cash Return on Invested Capital (CROIC)
7.86% 9.79% -34.11% -29.42% 4.47% 1.46% 8.86% -4.20% 4.60% 8.85% -4.45%
Operating Return on Assets (OROA)
2.83% 5.97% 7.94% -2.25% 4.65% -0.59% -3.87% -0.49% 5.07% 8.83% 8.88%
Return on Assets (ROA)
0.87% 2.15% 3.27% -4.10% 1.97% -2.14% -3.13% -0.40% 3.95% 8.02% 8.51%
Return on Common Equity (ROCE)
2.21% 5.35% 8.06% -12.21% 6.63% -6.73% -7.70% -0.80% 7.66% 17.32% 19.00%
Return on Equity Simple (ROE_SIMPLE)
2.48% 5.55% 7.66% -13.55% 6.75% -6.97% -7.02% -0.82% 7.50% 17.34% 0.00%
Net Operating Profit after Tax (NOPAT)
21 42 69 -35 95 -7.28 -56 -5.21 99 224 277
NOPAT Margin
1.13% 2.08% 3.44% -1.46% 3.81% -0.33% -2.80% -0.29% 4.58% 9.17% 11.72%
Net Nonoperating Expense Percent (NNEP)
2.82% 3.31% 2.99% 9.27% 4.90% 6.08% 4.27% 1.49% 0.48% -9.19% -11.15%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -0.31% 5.47% 8.43% 9.23%
Cost of Revenue to Revenue
70.44% 67.09% 66.47% 69.26% 69.94% 72.29% 71.08% 70.92% 67.16% 65.61% 62.31%
SG&A Expenses to Revenue
8.27% 15.87% 16.12% 17.81% 13.86% 12.74% 15.17% 16.18% 14.39% 13.89% 14.91%
R&D to Revenue
8.62% 8.33% 8.39% 8.75% 8.08% 8.93% 9.95% 10.31% 9.60% 8.81% 8.75%
Operating Expenses to Revenue
26.75% 27.89% 25.86% 32.83% 24.76% 28.19% 32.93% 29.50% 26.92% 23.57% 24.46%
Earnings before Interest and Taxes (EBIT)
49 97 146 -53 124 -16 -97 -12 126 265 316
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
127 167 211 76 244 86 5.68 59 186 327 373
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.27 3.81 3.36 2.62 4.28 4.74 2.78 1.96 2.62 3.52 2.48
Price to Tangible Book Value (P/TBV)
39.51 22.48 19.50 0.00 0.00 0.00 0.00 35.31 16.19 16.58 14.75
Price to Revenue (P/Rev)
0.73 1.19 1.31 0.78 1.33 1.78 1.57 1.27 1.58 2.01 1.80
Price to Earnings (P/E)
108.15 75.69 46.09 0.00 67.78 0.00 0.00 0.00 35.44 20.48 14.13
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.92% 1.32% 2.17% 0.00% 1.48% 0.00% 0.00% 0.00% 2.82% 4.88% 7.08%
Enterprise Value to Invested Capital (EV/IC)
1.89 3.16 2.49 1.71 2.54 2.89 2.39 1.75 2.40 3.19 2.28
Enterprise Value to Revenue (EV/Rev)
0.86 1.29 1.53 1.17 1.68 2.15 1.72 1.45 1.68 2.09 1.91
Enterprise Value to EBITDA (EV/EBITDA)
12.85 15.56 14.71 36.39 17.23 54.54 601.79 44.47 19.59 15.62 12.13
Enterprise Value to EBIT (EV/EBIT)
33.48 26.67 21.17 0.00 33.95 0.00 0.00 0.00 28.80 19.25 14.30
Enterprise Value to NOPAT (EV/NOPAT)
76.19 62.02 44.67 0.00 44.08 0.00 0.00 0.00 36.61 22.82 16.30
Enterprise Value to Operating Cash Flow (EV/OCF)
22.20 22.39 16.19 25.35 24.29 42.72 22.07 106.38 29.14 21.45 11.14
Enterprise Value to Free Cash Flow (EV/FCFF)
23.37 31.49 0.00 0.00 57.21 195.46 25.27 0.00 52.74 37.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.59 0.47 0.76 1.39 1.25 1.18 0.39 0.42 0.37 0.88 0.73
Long-Term Debt to Equity
0.58 0.45 0.74 1.35 1.25 1.15 0.39 0.42 0.37 0.88 0.47
Financial Leverage
0.34 0.32 0.42 0.87 1.14 0.99 0.54 0.25 0.19 0.14 0.15
Leverage Ratio
2.60 2.56 2.53 3.06 3.46 3.24 2.52 2.04 1.97 2.19 2.26
Compound Leverage Factor
1.98 2.23 2.33 6.29 2.05 11.73 3.23 2.76 1.99 2.35 2.45
Debt to Total Capital
37.28% 31.89% 43.22% 58.07% 55.57% 54.03% 28.26% 29.43% 26.80% 46.82% 42.18%
Short-Term Debt to Total Capital
1.13% 1.47% 1.39% 1.62% 0.00% 1.00% 0.00% 0.00% 0.00% 0.00% 15.29%
Long-Term Debt to Total Capital
36.15% 30.42% 41.83% 56.45% 55.57% 53.03% 28.26% 29.43% 26.80% 46.82% 26.89%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.81% 1.96% 1.35% 1.22% 1.35% 1.30% 1.68% 1.37% 1.13% 0.78% 0.72%
Common Equity to Total Capital
60.91% 66.15% 55.42% 40.71% 43.09% 44.67% 70.06% 69.20% 72.07% 52.40% 57.10%
Debt to EBITDA
2.92 1.83 2.91 13.30 4.11 11.51 79.31 8.48 2.62 3.80 3.40
Net Debt to EBITDA
1.89 1.03 2.08 11.73 3.49 9.10 50.67 5.03 1.00 0.58 0.66
Long-Term Debt to EBITDA
2.83 1.74 2.82 12.93 4.11 11.30 79.31 8.48 2.62 3.80 2.17
Debt to NOPAT
17.32 7.28 8.84 -29.23 10.52 -135.75 -8.11 -95.42 4.90 5.55 4.57
Net Debt to NOPAT
11.19 4.09 6.30 -25.77 8.94 -107.31 -5.18 -56.63 1.86 0.85 0.89
Long-Term Debt to NOPAT
16.80 6.94 8.56 -28.41 10.52 -133.22 -8.11 -95.42 4.90 5.55 2.91
Altman Z-Score
2.20 3.28 2.60 1.55 2.26 2.30 2.01 2.06 2.85 2.82 2.51
Noncontrolling Interest Sharing Ratio
2.69% 2.88% 2.61% 2.64% 2.98% 2.93% 2.54% 2.13% 1.73% 1.51% 1.35%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.59 1.77 1.67 1.37 1.49 1.69 1.50 1.66 1.95 3.44 1.80
Quick Ratio
0.97 1.17 1.13 0.85 0.93 1.05 0.92 0.97 1.13 2.65 1.37
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
70 82 -352 -423 73 24 135 -61 69 138 -80
Operating Cash Flow to CapEx
167.02% 266.04% 386.61% 183.07% 284.52% 237.00% 446.32% 124.07% 464.85% 779.32% 1,773.41%
Free Cash Flow to Firm to Interest Expense
5.67 6.09 -25.42 -7.26 1.40 0.54 4.72 -9.11 8.27 8.98 -3.58
Operating Cash Flow to Interest Expense
5.97 8.57 13.82 1.89 3.30 2.49 5.41 3.64 14.97 15.49 18.08
Operating Cash Flow Less CapEx to Interest Expense
2.40 5.35 10.25 0.86 2.14 1.44 4.19 0.71 11.75 13.50 17.06
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.10 1.24 1.10 1.01 0.94 0.82 0.79 0.75 0.87 0.81 0.66
Accounts Receivable Turnover
5.56 5.90 5.39 5.69 5.50 5.16 5.93 6.20 7.44 7.46 6.59
Inventory Turnover
7.70 7.64 7.52 7.94 7.80 7.66 8.09 6.46 5.70 5.78 5.74
Fixed Asset Turnover
9.48 10.98 10.70 11.12 10.89 9.86 10.68 11.84 16.17 19.99 20.80
Accounts Payable Turnover
7.18 7.53 6.17 5.75 5.49 5.78 6.89 5.92 6.69 9.30 9.79
Days Sales Outstanding (DSO)
65.64 61.86 67.78 64.15 66.37 70.77 61.55 58.84 49.05 48.92 55.38
Days Inventory Outstanding (DIO)
47.41 47.77 48.55 45.96 46.78 47.66 45.12 56.54 64.06 63.18 63.55
Days Payable Outstanding (DPO)
50.84 48.45 59.16 63.44 66.54 63.16 52.97 61.67 54.60 39.25 37.27
Cash Conversion Cycle (CCC)
62.20 61.18 57.17 46.67 46.61 55.26 53.70 53.71 58.52 72.85 81.65
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
862 821 1,243 1,630 1,652 1,621 1,430 1,486 1,517 1,603 1,986
Invested Capital Turnover
2.13 2.39 1.96 1.65 1.52 1.33 1.30 1.23 1.45 1.56 1.31
Increase / (Decrease) in Invested Capital
-48 -41 421 388 22 -31 -191 56 30 86 358
Enterprise Value (EV)
1,628 2,594 3,097 2,782 4,198 4,679 3,416 2,606 3,641 5,108 4,522
Market Capitalization
1,371 2,405 2,641 1,864 3,322 3,874 3,102 2,288 3,435 4,896 4,253
Book Value per Share
$15.96 $16.51 $20.31 $18.08 $19.63 $20.21 $24.65 $25.86 $28.82 $30.84 $37.48
Tangible Book Value per Share
$0.92 $2.80 $3.50 ($16.78) ($12.95) ($11.10) ($1.67) $1.43 $4.66 $6.55 $6.29
Total Capital
993 955 1,419 1,751 1,802 1,828 1,593 1,688 1,819 2,654 3,006
Total Debt
370 305 613 1,017 1,001 988 450 497 487 1,242 1,268
Total Long-Term Debt
359 290 594 988 1,001 969 450 497 487 1,242 808
Net Debt
239 171 437 896 851 781 288 295 185 191 248
Capital Expenditures (CapEx)
44 44 49 60 61 46 35 20 27 31 23
Debt-free, Cash-free Net Working Capital (DFCFNWC)
161 200 185 152 176 192 86 129 210 236 249
Debt-free Net Working Capital (DFNWC)
292 333 362 272 326 399 249 331 512 1,288 1,270
Net Working Capital (NWC)
281 319 342 243 326 380 249 331 512 1,288 810
Net Nonoperating Expense (NNE)
6.37 6.78 9.09 62 43 50 23 4.34 1.14 -17 -26
Net Nonoperating Obligations (NNO)
239 171 437 896 851 781 288 295 185 191 248
Total Depreciation and Amortization (D&A)
78 69 64 130 120 101 102 70 59 62 57
Debt-free, Cash-free Net Working Capital to Revenue
8.57% 9.93% 9.19% 6.38% 7.03% 8.82% 4.34% 7.18% 9.67% 9.68% 10.53%
Debt-free Net Working Capital to Revenue
15.52% 16.56% 17.92% 11.44% 13.02% 18.35% 12.54% 18.44% 23.56% 52.75% 53.63%
Net Working Capital to Revenue
14.93% 15.87% 16.94% 10.25% 13.02% 17.50% 12.54% 18.44% 23.56% 52.75% 34.22%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.33 $0.83 $1.48 ($2.53) $1.24 ($1.44) ($1.83) ($0.22) $2.13 $5.27 $6.62
Adjusted Weighted Average Basic Shares Outstanding
38.22M 38.21M 38.66M 39.24M 39.56M 40.25M 44.30M 45.10M 45.42M 45.37M 45.49M
Adjusted Diluted Earnings per Share
$0.33 $0.82 $1.45 ($2.53) $1.23 ($1.44) ($1.83) ($0.22) $2.11 $5.18 $6.50
Adjusted Weighted Average Diluted Shares Outstanding
38.51M 38.64M 39.39M 39.24M 39.98M 40.25M 44.30M 45.10M 45.84M 46.19M 46.32M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
-27M 38.33M 38.78M 39.54M 39.96M 40.46M 45.01M 45.29M 45.58M 45.18M 44.94M
Normalized Net Operating Profit after Tax (NOPAT)
32 105 113 19 100 61 28 15 134 227 278
Normalized NOPAT Margin
1.69% 5.22% 5.59% 0.81% 3.99% 2.78% 1.40% 0.82% 6.16% 9.28% 11.76%
Pre Tax Income Margin
1.97% 4.20% 6.67% -4.59% 2.92% -2.61% -6.25% -0.88% 5.86% 11.66% 14.46%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.96 7.20 10.57 -0.91 2.36 -0.36 -3.38 -1.73 15.14 17.25 14.09
NOPAT to Interest Expense
1.74 3.09 5.01 -0.60 1.82 -0.17 -1.94 -0.77 11.91 14.55 12.36
EBIT Less CapEx to Interest Expense
0.38 3.97 6.99 -1.94 1.20 -1.41 -4.59 -4.67 11.92 15.27 13.07
NOPAT Less CapEx to Interest Expense
-1.83 -0.13 1.43 -1.63 0.66 -1.22 -3.15 -3.71 8.69 12.57 11.34
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
255.17% 0.00% 0.00% 0.00% 47.70% 0.00% -10.25% -177.77% 0.00% 41.47% 32.97%

Quarterly Metrics And Ratios for Itron

This table displays calculated financial ratios and metrics derived from Itron's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 44,941,206.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 44,941,206.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.19
Growth Metrics
- - - - - - - - - - -
Revenue Growth
33.24% 23.46% 22.00% 12.57% 9.75% 6.18% 0.61% -0.38% -5.50% -6.72% -3.32%
EBITDA Growth
191.28% 120.96% 2,107.09% 58.66% 29.96% 28.32% 17.06% 15.30% 6.05% 18.87% -2.54%
EBIT Growth
853.74% 324.35% 633.06% 84.66% 34.35% 31.83% 20.39% 19.66% 10.95% 27.37% -11.58%
NOPAT Growth
537.88% 77.46% 785.47% 94.66% 78.13% 17.58% 21.38% 25.84% -15.64% 79.54% -10.97%
Net Income Growth
802.17% 104.59% 530.23% 106.59% 95.59% 30.42% 26.19% 32.57% -16.08% 75.88% -18.00%
EPS Growth
866.67% 97.96% 530.77% 107.55% 95.40% 29.90% 26.79% 33.64% -17.06% 74.60% -16.90%
Operating Cash Flow Growth
129.17% 467.57% 2,790.69% 24.44% 91.57% 66.72% 74.58% 86.95% 80.44% 49.43% 18.56%
Free Cash Flow Firm Growth
-175.06% 146.43% -232.76% -4,155.14% -33.20% -331.63% 25.51% 84.05% 153.91% -350.15% -2,772.08%
Invested Capital Growth
6.38% 2.05% 6.12% 8.97% 9.19% 5.65% 5.82% 4.79% 1.48% 21.98% 54.52%
Revenue Q/Q Growth
3.64% 2.92% 4.55% 0.93% 1.05% -0.42% -0.93% -0.06% -4.14% -1.71% 2.68%
EBITDA Q/Q Growth
41.37% -10.67% 22.76% 2.35% 15.79% -11.80% 11.99% 0.81% 6.50% -1.13% -8.18%
EBIT Q/Q Growth
59.74% -13.59% 31.84% 1.48% 16.21% -15.22% 20.40% 0.87% 7.75% -2.66% -16.42%
NOPAT Q/Q Growth
54.67% 12.58% 11.48% 0.28% 41.54% -25.69% 15.09% 3.96% -5.11% 58.15% -42.93%
Net Income Q/Q Growth
60.72% 11.31% 15.32% 0.14% 52.16% -25.78% 11.58% 5.21% -3.68% 55.55% -47.98%
EPS Q/Q Growth
64.15% 11.49% 15.46% -1.79% 54.55% -25.88% 12.70% 3.52% -4.08% 56.03% -46.36%
Operating Cash Flow Q/Q Growth
-17.98% 40.51% -13.75% 25.20% 26.27% 22.28% -9.68% 34.07% 21.87% 1.27% -28.34%
Free Cash Flow Firm Q/Q Growth
-2,614.77% 128.83% -183.06% -105.19% 17.40% 49.86% 12.35% 56.06% 379.13% -838.85% -216.92%
Invested Capital Q/Q Growth
2.79% 1.79% 3.77% 2.58% 2.99% -1.51% 1.69% 1.58% -0.26% 20.26% 26.81%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
33.38% 34.03% 34.03% 34.55% 34.06% 34.90% 35.78% 36.85% 37.75% 40.54% 40.26%
EBITDA Margin
12.50% 10.85% 12.74% 12.92% 14.81% 13.11% 14.83% 14.96% 16.62% 16.71% 14.95%
Operating Margin
9.79% 8.54% 10.41% 10.61% 12.01% 10.24% 12.55% 12.59% 14.06% 13.76% 11.51%
EBIT Margin
9.90% 8.31% 10.48% 10.54% 12.12% 10.32% 12.54% 12.66% 14.23% 14.09% 11.47%
Profit (Net Income) Margin
7.19% 7.78% 8.58% 8.51% 12.82% 9.56% 10.76% 11.33% 11.39% 18.02% 9.13%
Tax Burden Percent
72.39% 90.79% 79.41% 77.36% 95.74% 83.85% 79.42% 82.36% 73.01% 120.05% 79.75%
Interest Burden Percent
100.35% 103.08% 103.09% 104.42% 110.47% 110.42% 108.03% 108.66% 109.57% 106.49% 99.78%
Effective Tax Rate
27.61% 9.21% 20.59% 22.64% 4.26% 16.15% 20.58% 17.64% 26.99% -20.05% 20.25%
Return on Invested Capital (ROIC)
10.12% 11.22% 12.61% 12.74% 17.75% 13.43% 15.38% 15.66% 15.08% 21.64% 10.39%
ROIC Less NNEP Spread (ROIC-NNEP)
10.35% 11.29% 13.54% 13.43% 21.06% 16.60% 18.88% 19.08% 21.72% 25.34% 10.33%
Return on Net Nonoperating Assets (RNNOA)
2.25% 2.15% 2.16% 2.91% 3.94% 2.28% 1.80% 2.24% 1.38% 3.73% 3.32%
Return on Equity (ROE)
12.37% 13.37% 14.77% 15.65% 21.68% 15.71% 17.17% 17.90% 16.47% 25.38% 13.71%
Cash Return on Invested Capital (CROIC)
-0.78% 4.60% 4.76% 3.58% 5.06% 8.85% 9.13% 10.59% 12.91% -4.45% -29.76%
Operating Return on Assets (OROA)
8.47% 7.25% 9.34% 8.57% 9.92% 8.38% 9.92% 8.95% 9.69% 9.36% 7.20%
Return on Assets (ROA)
6.15% 6.79% 7.65% 6.92% 10.49% 7.76% 8.52% 8.01% 7.75% 11.97% 5.73%
Return on Common Equity (ROCE)
12.14% 13.14% 14.52% 15.37% 21.35% 15.47% 16.93% 17.64% 16.25% 25.03% 13.53%
Return on Equity Simple (ROE_SIMPLE)
6.09% 0.00% 11.88% 15.24% 16.87% 0.00% 17.11% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
40 45 50 50 71 53 61 63 60 94 54
NOPAT Margin
7.09% 7.75% 8.26% 8.21% 11.50% 8.58% 9.97% 10.37% 10.27% 16.52% 9.18%
Net Nonoperating Expense Percent (NNEP)
-0.24% -0.07% -0.93% -0.69% -3.31% -3.17% -3.50% -3.42% -6.64% -3.70% 0.06%
Return On Investment Capital (ROIC_SIMPLE)
- 2.46% - - - 1.98% 2.20% 2.19% 2.00% 3.14% 1.67%
Cost of Revenue to Revenue
66.62% 65.97% 65.97% 65.45% 65.94% 65.10% 64.22% 63.15% 62.25% 59.46% 59.74%
SG&A Expenses to Revenue
13.66% 14.14% 14.25% 14.52% 12.94% 13.88% 14.31% 14.44% 14.29% 16.67% 17.95%
R&D to Revenue
9.21% 9.34% 8.68% 8.71% 8.33% 9.52% 8.25% 8.87% 8.60% 9.29% 9.37%
Operating Expenses to Revenue
23.59% 25.49% 23.63% 23.94% 22.04% 24.66% 23.22% 24.26% 23.69% 26.78% 28.75%
Earnings before Interest and Taxes (EBIT)
56 48 63 64 75 63 76 77 83 81 67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
70 63 77 79 91 80 90 91 97 96 88
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.23 2.62 3.08 3.66 3.56 3.52 3.18 3.72 3.36 2.48 2.51
Price to Tangible Book Value (P/TBV)
18.17 16.19 17.30 35.76 21.19 16.58 12.23 12.23 9.90 14.75 0.00
Price to Revenue (P/Rev)
1.33 1.58 1.84 1.93 2.00 2.01 1.94 2.46 2.36 1.80 1.72
Price to Earnings (P/E)
36.84 35.44 26.23 24.20 21.31 20.48 18.72 22.23 22.11 14.13 13.94
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.71% 2.82% 3.81% 4.13% 4.69% 4.88% 5.34% 4.50% 4.52% 7.08% 7.18%
Enterprise Value to Invested Capital (EV/IC)
2.02 2.40 2.85 3.09 3.12 3.19 2.99 3.65 3.42 2.28 1.96
Enterprise Value to Revenue (EV/Rev)
1.46 1.68 1.92 2.08 2.11 2.09 1.99 2.47 2.35 1.91 2.10
Enterprise Value to EBITDA (EV/EBITDA)
19.84 19.59 16.91 16.92 16.43 15.62 14.33 17.16 15.80 12.13 13.33
Enterprise Value to EBIT (EV/EBIT)
33.50 28.80 21.75 21.12 20.32 19.25 17.52 20.78 18.90 14.30 16.06
Enterprise Value to NOPAT (EV/NOPAT)
38.47 36.61 27.39 26.48 23.54 22.82 20.80 24.46 23.98 16.30 18.21
Enterprise Value to Operating Cash Flow (EV/OCF)
46.94 29.14 26.60 27.88 24.64 21.45 18.12 19.25 15.42 11.14 11.78
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 52.74 61.61 90.04 64.37 37.00 33.67 35.27 26.70 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.39 0.37 0.33 0.98 0.91 0.88 0.82 0.76 0.74 0.73 0.98
Long-Term Debt to Equity
0.39 0.37 0.33 0.98 0.91 0.88 0.52 0.48 0.47 0.47 0.98
Financial Leverage
0.22 0.19 0.16 0.22 0.19 0.14 0.10 0.12 0.06 0.15 0.32
Leverage Ratio
2.03 1.97 1.99 2.32 2.24 2.19 2.14 2.39 2.30 2.26 2.38
Compound Leverage Factor
2.04 2.04 2.05 2.43 2.47 2.42 2.31 2.59 2.52 2.41 2.38
Debt to Total Capital
27.92% 26.80% 24.74% 49.58% 47.55% 46.82% 45.18% 43.24% 42.56% 42.18% 49.58%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.63% 15.92% 15.38% 15.29% 0.00%
Long-Term Debt to Total Capital
27.92% 26.80% 24.74% 49.58% 47.55% 46.82% 28.56% 27.33% 27.18% 26.89% 49.58%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.15% 1.13% 1.12% 0.85% 0.78% 0.78% 0.75% 0.73% 0.68% 0.72% 0.67%
Common Equity to Total Capital
70.93% 72.07% 74.14% 49.57% 51.67% 52.40% 54.06% 56.02% 56.76% 57.10% 49.74%
Debt to EBITDA
3.22 2.62 1.76 4.30 4.01 3.80 3.66 3.54 3.55 3.40 4.32
Net Debt to EBITDA
1.53 1.00 0.60 1.11 0.84 0.58 0.35 0.06 -0.17 0.66 2.40
Long-Term Debt to EBITDA
3.22 2.62 1.76 4.30 4.01 3.80 2.31 2.23 2.27 2.17 4.32
Debt to NOPAT
6.24 4.90 2.85 6.73 5.75 5.55 5.31 5.04 5.39 4.57 5.91
Net Debt to NOPAT
2.98 1.86 0.97 1.73 1.20 0.85 0.51 0.09 -0.26 0.89 3.28
Long-Term Debt to NOPAT
6.24 4.90 2.85 6.73 5.75 5.55 3.35 3.19 3.44 2.91 5.91
Altman Z-Score
2.43 2.75 2.92 2.41 2.57 2.62 2.46 2.87 2.81 2.30 2.02
Noncontrolling Interest Sharing Ratio
1.83% 1.73% 1.68% 1.80% 1.54% 1.51% 1.43% 1.46% 1.32% 1.35% 1.35%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.82 1.95 1.90 3.16 3.36 3.44 1.93 2.04 2.17 1.80 2.66
Quick Ratio
1.03 1.13 1.11 2.31 2.53 2.65 1.49 1.61 1.72 1.37 1.93
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-50 14 -39 -80 -66 -33 -29 -13 36 -263 -835
Operating Cash Flow to CapEx
587.10% 558.22% 578.14% 727.38% 985.97% 824.55% 1,554.58% 1,606.86% 2,665.21% 1,527.02% 1,309.96%
Free Cash Flow to Firm to Interest Expense
-20.30 7.65 -20.61 -34.96 -11.80 -5.93 -5.20 -2.26 6.31 -47.34 -143.68
Operating Cash Flow to Interest Expense
13.94 25.61 21.82 22.58 11.65 14.28 12.89 17.12 20.87 21.45 14.72
Operating Cash Flow Less CapEx to Interest Expense
11.57 21.02 18.05 19.48 10.47 12.55 12.06 16.05 20.08 20.04 13.60
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.86 0.87 0.89 0.81 0.82 0.81 0.79 0.71 0.68 0.66 0.63
Accounts Receivable Turnover
7.06 7.44 7.07 7.40 7.32 7.46 7.12 7.43 6.80 6.59 6.35
Inventory Turnover
5.86 5.70 5.50 5.55 5.73 5.78 5.60 5.49 5.77 5.74 5.50
Fixed Asset Turnover
15.38 16.17 17.46 18.46 19.23 19.99 20.59 20.56 20.72 20.80 20.00
Accounts Payable Turnover
6.11 6.69 6.49 7.39 8.40 9.30 8.21 10.25 10.30 9.79 8.51
Days Sales Outstanding (DSO)
51.71 49.05 51.59 49.35 49.84 48.92 51.25 49.10 53.67 55.38 57.52
Days Inventory Outstanding (DIO)
62.28 64.06 66.34 65.75 63.71 63.18 65.18 66.51 63.27 63.55 66.32
Days Payable Outstanding (DPO)
59.74 54.60 56.26 49.39 43.43 39.25 44.44 35.61 35.43 37.27 42.88
Cash Conversion Cycle (CCC)
54.25 58.52 61.67 65.72 70.12 72.85 72.00 80.00 81.51 81.65 80.97
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,490 1,517 1,540 1,580 1,627 1,603 1,630 1,656 1,651 1,986 2,518
Invested Capital Turnover
1.43 1.45 1.53 1.55 1.54 1.56 1.54 1.51 1.47 1.31 1.13
Increase / (Decrease) in Invested Capital
89 30 89 130 137 86 90 76 24 358 889
Enterprise Value (EV)
3,006 3,641 4,384 4,879 5,081 5,108 4,874 6,043 5,653 4,522 4,939
Market Capitalization
2,754 3,435 4,209 4,539 4,802 4,896 4,733 6,001 5,695 4,253 4,028
Book Value per Share
$27.23 $28.82 $29.89 $27.02 $29.99 $30.84 $32.94 $35.39 $37.04 $37.48 $35.76
Tangible Book Value per Share
$3.33 $4.66 $5.33 $2.77 $5.04 $6.55 $8.57 $10.76 $12.59 $6.29 ($8.12)
Total Capital
1,745 1,819 1,841 2,500 2,610 2,654 2,753 2,880 2,983 3,006 3,231
Total Debt
487 487 455 1,240 1,241 1,242 1,244 1,245 1,270 1,268 1,602
Total Long-Term Debt
487 487 455 1,240 1,241 1,242 786 787 811 808 1,602
Net Debt
233 185 155 319 258 191 121 21 -62 248 889
Capital Expenditures (CapEx)
5.81 8.58 7.15 7.11 6.62 9.68 4.64 6.02 4.42 7.81 6.53
Debt-free, Cash-free Net Working Capital (DFCFNWC)
199 210 218 234 251 236 254 250 284 249 238
Debt-free Net Working Capital (DFNWC)
454 512 519 1,154 1,233 1,288 1,377 1,474 1,616 1,270 951
Net Working Capital (NWC)
454 512 519 1,154 1,233 1,288 919 1,016 1,157 810 951
Net Nonoperating Expense (NNE)
-0.61 -0.17 -1.92 -1.85 -8.13 -5.97 -4.82 -5.82 -6.51 -8.58 0.30
Net Nonoperating Obligations (NNO)
233 185 155 319 258 191 121 21 -62 248 889
Total Depreciation and Amortization (D&A)
15 15 14 14 17 17 14 14 14 15 20
Debt-free, Cash-free Net Working Capital to Revenue
9.64% 9.67% 9.56% 9.94% 10.42% 9.68% 10.37% 10.23% 11.78% 10.53% 10.15%
Debt-free Net Working Capital to Revenue
21.99% 23.56% 22.73% 49.11% 51.27% 52.75% 56.32% 60.36% 67.08% 53.63% 40.52%
Net Working Capital to Revenue
21.99% 23.56% 22.73% 49.11% 51.27% 52.75% 37.60% 41.59% 48.03% 34.22% 40.52%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.88 $0.98 $1.13 $1.12 $1.73 $1.29 $1.44 $1.50 $1.43 $2.25 $1.20
Adjusted Weighted Average Basic Shares Outstanding
45.46M 45.42M 45.65M 45.75M 44.98M 45.37M 45.34M 45.63M 45.75M 45.49M 44.73M
Adjusted Diluted Earnings per Share
$0.87 $0.97 $1.12 $1.10 $1.70 $1.26 $1.42 $1.47 $1.41 $2.20 $1.18
Adjusted Weighted Average Diluted Shares Outstanding
45.95M 45.84M 46.36M 46.53M 45.84M 46.19M 46.17M 46.38M 46.66M 46.32M 45.47M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
45.49M 45.58M 45.87M 44.96M 45.09M 45.18M 45.59M 45.72M 45.80M 44.94M 44.34M
Normalized Net Operating Profit after Tax (NOPAT)
39 51 50 50 71 55 60 64 60 55 54
Normalized NOPAT Margin
7.01% 8.87% 8.29% 8.19% 11.50% 9.03% 9.91% 10.54% 10.29% 9.64% 9.21%
Pre Tax Income Margin
9.94% 8.57% 10.81% 11.01% 13.39% 11.40% 13.55% 13.76% 15.59% 15.01% 11.45%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
22.71 25.66 33.42 28.04 13.31 11.31 13.62 13.60 14.66 14.48 11.59
NOPAT to Interest Expense
16.25 23.92 26.34 21.84 12.63 9.41 10.82 11.14 10.57 16.97 9.28
EBIT Less CapEx to Interest Expense
20.34 21.07 29.65 24.93 12.13 9.58 12.79 12.54 13.88 13.08 10.47
NOPAT Less CapEx to Interest Expense
13.88 19.33 22.57 18.73 11.45 7.68 9.99 10.08 9.79 15.57 8.15
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 52.94% 43.96% 41.47% 0.00% 0.00% 0.00% 32.97% 68.59%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from ITRON, INC. (ITRI) quarterly statements over the last four years, focusing on trends most relevant to retail investors.

  • Net income to common shareholders jumped to $101.6 million in Q4 2025, with diluted earnings per share (EPS) of $2.20, up from $58.1 million and $0.87 in Q4 2024, respectively.
  • Gross margin expansion improved to about 40.6% in Q4 2025 (gross profit of $231.7 million on $571.7 million revenue) versus roughly 34.9% a year earlier, signaling better pricing and cost control.
  • Operating cash flow strength remained solid and rose in Q4 2025 to about $119.3 million, supported by ongoing cash-generation from operations (versus lower levels in prior periods).
  • Healthy liquidity position as of mid-2025 shows cash and equivalents around $1.33 billion, contributing to a robust liquidity cushion for operations and growth initiatives.
  • Net cash position remained favorable, with approximate net cash around $80–90 million during mid-2025 (cash levels exceeding combined short- and long-term debt), providing balance-sheet flexibility.
  • Equity base strengthening total equity rose to about $1.69 billion by Q3 2025, reflecting a stronger balance sheet and improved capitalization.
  • Revenue has stayed at a meaningful scale, typically in the mid-$500 million to roughly $610 million range across recent quarters, illustrating ongoing market presence but with limited clear year-over-year growth in some periods.
  • The company engaged in acquisitions in late 2025 (e.g., a substantial $325 million outlay in Q4 2025), which supports growth but also adds near-term cash outflow and investing activity that can impact short-term free cash flow.
  • Debt levels remain manageable and largely offset by cash holdings in several periods, helping to keep leverage at reasonable levels relative to earnings power.
  • Short-term cash impact from investing activity in Q4 2025 included a large net cash outflow (net change in cash around −$311.5 million), driven by acquisitions and investment spending, which weighed on quarterly cash flow despite strong earnings.
05/19/26 10:13 AM ETAI Generated. May Contain Errors.

Itron Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Itron's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Itron's net income appears to be on an upward trend, with a most recent value of $303.34 million in 2025, rising from $15.00 million in 2015. The previous period was $241.12 million in 2024. View Itron's forecast to see where analysts expect Itron to go next.

Itron's total operating income in 2025 was $313.07 million, based on the following breakdown:
  • Total Gross Profit: $892.12 million
  • Total Operating Expenses: $579.05 million

Over the last 10 years, Itron's total revenue changed from $1.88 billion in 2015 to $2.37 billion in 2025, a change of 25.7%.

Itron's total liabilities were at $1.98 billion at the end of 2025, a 0.7% decrease from 2024, and a 87.5% increase since 2015.

In the past 10 years, Itron's cash and equivalents has ranged from $120.22 million in 2018 to $1.05 billion in 2024, and is currently $1.02 billion as of their latest financial filing in 2025.

Over the last 10 years, Itron's book value per share changed from 15.96 in 2015 to 37.48 in 2025, a change of 134.9%.



Financial statements for NASDAQ:ITRI last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners